Fresenius Medical Care AG (LON:0H9X)

Market Cap	10.57B
Revenue (ttm)	15.99B
Net Income (ttm)	444.84M
Shares Out	n/a
EPS (ttm)	1.51
PE Ratio	23.76
Forward PE	n/a
Dividend	1.02 (2.45%)
Ex-Dividend Date	May 23, 2025

Volume	310,995
Average Volume	118,328
Open	43.84
Previous Close	n/a
Day's Range	41.50 - 43.15
52-Week Range	26.92 - 38.27
Beta	0.91
RSI	43.88
Earnings Date	May 6, 2025

About Fresenius Medical Care AG

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospital...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1996
• Employees: 111,513
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0H9X

Financial Performance

In 2024, Fresenius Medical Care AG's revenue was 19.34 billion, a decrease of -0.61% compared to the previous year's 19.45 billion. Earnings were 537.91 million, an increase of 7.80%.

Financial numbers in EUR